Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India

INTRODUCTION: There is a scarcity of data from India on the impact of cell of origin (COO) on outcomes of diffuse large B-cell lymphoma (DLBCL). This study was conducted to evaluate the impact of COO on outcomes of DLBCL patients treated with uniform rituximab, cyclophosphamide, doxorubicin, vincris...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogia, Ajay, Nair, Sukesh, Arora, Shalabh, Kumar, Lalit, Sharma, Atul, Gupta, Ritu, Biswas, Ahitagni, Mallick, Saumyaranjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675100/
https://www.ncbi.nlm.nih.gov/pubmed/34926277
http://dx.doi.org/10.3389/fonc.2021.770747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675100/
https://www.ncbi.nlm.nih.gov/pubmed/34926277
http://dx.doi.org/10.3389/fonc.2021.770747

Ejemplares similares